Knowledge and Attitude of Dentists Regarding Patients Undergoing Bisphosphonate Treatment: a Comparative Questionnaire

1. Marx RE. Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: A growing epidemic. J Oral Maxillofac Surg. 2003;61:1115-1117.10.1016/S0278-2391(03)00720-1Search in Google Scholar

2. Ruggiero SL, Dodson TB, Assael LA, et al. American association of oral and maxillofacial surgeons position paper on bisphosphonate-related osteonecrosis of the jaws-2009 update. J Oral Maxillofac Surg. 2009;67:2-12.10.1016/j.joms.2009.01.009Search in Google Scholar

3. Pittman K, Antill YC, Goldrick A, Goh J, de Boer RH. Denosumab: Prevention and management of hypocalcemia, osteonecrosis of the jaw and atypical fractures. Asia Pac J Clin Oncol. 2017;13:266-276.10.1111/ajco.12517Search in Google Scholar

4. Ruggiero SL, Mehrotra B, Rosenberg TJ, Engroff SL. Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 cases. J Oral Maxillofac Surg. 2004;62:527-534.10.1016/j.joms.2004.02.004Search in Google Scholar

5. Wood J, Bonjean K, Ruetz S, et al. Novel antiangiogenic effects of the bisphosphonate compound zoledronic acid. J Pharmacol Exp Ther. 2002;302:1055-1061.10.1124/jpet.102.035295Search in Google Scholar

6. Yamashita J, McCauley LK. Antiresorptives and osteonecrosis of the jaw. J Evid Base Dent Pract. 2012:S1:233-247.10.1016/S1532-3382(12)70046-5Search in Google Scholar

7. Saia G, Blandamura S, Bettini G, et al. Occurrence of bisphosphonate-related osteonecrosis of the jaw after surgical tooth extraction. J Oral Maxillofac Surg. 2010;68:797-804.10.1016/j.joms.2009.10.02620307765Search in Google Scholar

8. Conte Neto N, Spolidorio LC, Andrade CR, Bastos S, Guimarães A, Marcantonio ME Jr. Experimental development of bisphosphonate-related osteonecrosis of the jaws in rodents. Int J Exp Pathol. 2013;94:65-73.10.1111/iep.12007357587523317355Search in Google Scholar

9. Marx RE, Sawatari Y, Fortin M, Broumand V. Bisphosphonate-Induced Exposed Bone (Osteonecrosis/Osteopetrosis) of the Jaws: Risk Factors, Recognition, Prevention, and Treatment. J Oral Maxillofac Surg. 2005;63:1567-1575.10.1016/j.joms.2005.07.01016243172Search in Google Scholar

10. Kumar SK, Gorur A, Schaudinn C, Shuler CF, Costerton JW, Sedghizadeh PP. The role of microbial biofilms in osteonecrosis of the jaw associated with bisphosphonate therapy. Curr Osteoporos Rep. 2010;8:40-48.10.1007/s11914-010-0008-120425090Search in Google Scholar

11. Solomon DH, Mercer E, Woo SB, Avorn J, Schneeweiss S, Treister N. Defining the epidemiology of bisphosphonate-associated osteonecrosis of the jaw: prior work and current challenges. Osteoporosis International. 2013;24:237-244.10.1007/s00198-012-2042-622707065Search in Google Scholar

12. Walter C, Al-Nawas B, Grotz KA, et al. Prevalence and risk factors of bisphosphonate-associated osteonecrosis of the jaw in prostate cancer patients with advanced disease treated with zoledronate. European Urology. 2008;54:1066-1072.10.1016/j.eururo.2008.06.07018602738Search in Google Scholar

13. Badros A, Weikel D, Salama A, et al. Osteonecrosis of the jaw in multiple myeloma patients: Clinical features and risk factors. J Clin Oncol. 2006;24:945.10.1200/JCO.2005.04.246516484704Search in Google Scholar

14. Ruggiero SL, Dodson TB, Fantasia J, et al. American Association of Oral and Maxillofacial Surgeons position paper on medication-related osteonecrosis of the jaw – 2014 update. J Oral Maxillofac Surg. 2014;72:1938-1956.10.1016/j.joms.2014.04.03125234529Search in Google Scholar

15. Albu IA, Petrovan C, Păcurar M, et al. Biophosphonate-Related Osteonecrosis of the Jaws: A Real Challenge for Dentists. Acta Medica Marisiensis. 2015;61:115-119.10.1515/amma-2015-0034Search in Google Scholar

16. Mercer E, Norton T, Woo S, Treister N, Dodson TB, Solomon DH. Ninety-one osteoporosis patients affected with bisphosphonate-related osteonecrosis of the jaw: a case series. Calcif Tissue Int. 2013;93:241-248.10.1007/s00223-013-9747-1374462123756612Search in Google Scholar

17. Lazarovici TS, Yahalom R, Taicher S, Elad S, Hardan I, Yarom N. Bisphosphonate-related osteonecrosis of the jaws: a single-center study of 101 patients. J Oral Maxillofac Surg. 2009;67:850-855.10.1016/j.joms.2008.11.01519304045Search in Google Scholar

18. Nicolatou-Galitis O, Papadopoulou E, Sarri T, et al. Osteonecrosis of the jaw in oncology patients treated with bisphosphonates: prospective experience of a dental oncology referral center. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2011;112:195-202.10.1016/j.tripleo.2011.02.03721622014Search in Google Scholar

19. Hallmer F, Bjørnland T, Nicklasson A, Becktor JP, Andersson G. Osteonecrosis of the jaw in patients treated with oral and intravenous bisphosphonates: experience in Sweden. Oral Surg Oral Med Oral Pathol Oral Radiol. 2014;118:202-208.10.1016/j.oooo.2014.05.00625047929Search in Google Scholar

20. Bauer JS, Beck N, Kiefer J, Stockmann P, Wichmann M, Eitner S. Awareness and education of patients receiving bisphosphonates. J Craniomaxillofac Surg. 2012;40:277-282.10.1016/j.jcms.2011.04.01121612939Search in Google Scholar

21. Allen MR, Burr DB. The pathogenesis of bisphosphonate-related osteonecrosis of the jaw: so many hypotheses, so few data. J Oral Maxillofac Surg. 2009;67:61-70.10.1016/j.joms.2009.01.00719371816Search in Google Scholar

22. Migliorati CA, Casiglia J, Epstein J, Jacobsen PL, Siegel MA, Woo SB. Managing the care of patients with bisphosphonate-associated osteonecrosis: an American Academy of Oral Medicine position paper. J Am Dent Assoc. 2005;136:1658-1668.10.14219/jada.archive.2005.010816383047Search in Google Scholar

23. Ji X, Pushalkar S, Li Y, Glickman R, Fleisher K, Saxena D. Antibiotic effects on bacterial profile in osteonecrosis of the jaw. Oral Dis. 2012;18:85-95.10.1111/j.1601-0825.2011.01848.x323232721883710Search in Google Scholar

24. Berti-Couto SA, Vasconcelos AC, Iglesias JE, Figueiredo MA, Salum FG, Cherubini K. Diabetes mellitus and corticotherapy as risk factors for alendronate-related osteonecrosis of the jaws: a study in Wistar rats. Head Neck. 2014;36:84-93.10.1002/hed.2326023649954Search in Google Scholar

25. Drake MT, Clarke BL, Lewiecki EM. The Pathophysiology and Treatment of Osteoporosis. Clin Ther. 2015;37:1837-1850.10.1016/j.clinthera.2015.06.00626163201Search in Google Scholar